Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
4(44%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
22%
Ph phase_4
1
11%
Ph not_applicable
1
11%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(5)

Detailed Status

Completed5
Recruiting3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

completed556%
recruiting333%
active_not_recruiting111%

Recent Activity

4 active trials
Showing 5 of 9
active_not_recruitingphase_2

Cabozantinib in High Grade Neuroendocrine Neoplasms

NCT04412629
recruiting

Muscle Connective Tissue in Limb Development and Disease

NCT02611089
recruiting

LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions

NCT05293366
recruiting

Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy

NCT06946745
completednot_applicable

Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients

NCT06148129
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04412629Phase 2

Cabozantinib in High Grade Neuroendocrine Neoplasms

Active Not Recruiting
NCT02611089

Muscle Connective Tissue in Limb Development and Disease

Recruiting
NCT05293366

LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions

Recruiting
NCT06946745

Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy

Recruiting
NCT06148129Not Applicable

Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients

Completed
NCT02203136

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

Completed
NCT03228810

Genetic Biomarker Discovery for Metastatic Prostate Cancer

Completed
NCT00851461Phase 4

Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy

Completed
NCT00001956Phase 2

Influence of Genetics in Pain Sensitivity

Completed

All 9 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
9